Variable | No. of patients (%) | ||
---|---|---|---|
Pattern of failure | N Group | CRT Group | P |
Distant metastasis | 5a (15.6%) | 7b (12.7%) | 0.753 |
Local and/or regional failures | 10a (31.3%) | 19b (34.5%) | 0.753 |
Local failures alone | 3 (9.4%) | 9 (16.4%) | 0.523 |
Regional failures alone | 1 (3.1%) | 1 (1.8%) | 1.000 |
Local and regional failures | 6 (18.8%) | 9 (16.4%) | 0.776 |
Distant + local/regional failures | 2 (6.3%) | 5 (9.0%) | 1.000 |
Total | 13 (43.8%) | 21 (38.2%) | 0.822 |
Cause of death | |||
Tumor progression | 8 (25.0%) | 7 (12.7%) | 0.144 |
Distant metastasis | 2 (6.3%) | 1 (1.8%) | 0.552 |
Local or regional failure | 5 (15.6%) | 2 (3.6%) | 0.095 |
Distant + local/regional failures | 1 (3.1%) | 4 (7.3%) | 0.648 |
Radiation-related complications | 8 (25.0%) | 18 (32.7%) | 0.448 |
Organ failure caused by tumor | 1 (3.1%) | 1 (1.8%) | 1.000 |
No cancer causes | 4 (12.5%) | 1 (1.8%) | 0.059 |
Unknown causes | 0 (0.0%) | 1 (1.8%) | 1.000 |
Total | 21 (65.6%) | 28 (50.9%) | 0.182 |